NCT03185403

Brief Summary

Continuous Paravertebral block (PVB) was reported to provide less episodes of hypotension than continuous thoracic epidural block (TEB). The maintenance of optimal tissue perfusion is essential for esophageal anastomosis in patients undergoing oesophagectomy. the aim of this study is to compare Hemodynamic effect of continous PVB compared to TEB , in patient undergoing oesophagectomy with laparoscopy and thoracotomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 30, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 14, 2017

Completed
Last Updated

June 14, 2017

Status Verified

June 1, 2017

Enrollment Period

2.6 years

First QC Date

May 30, 2017

Last Update Submit

June 12, 2017

Conditions

Keywords

hemodynamic effectpara vertebral block

Outcome Measures

Primary Outcomes (1)

  • Frequency of hypotension episodes

    The frequency of hypotension episodes defined by a mean arterial pressure (MAP) less than 70mmHg or a decrease in MAP greater than 20% when compared with the preoperative value

    during perioperative until first 24 hours post operative

Secondary Outcomes (10)

  • Total amount per patient and per group of vasopressins amines

    during perioperative until first 24 hours post operative

  • Frequency of use of vasopressor agents

    during perioperative until first 24 hours post operative

  • Volumes of fluid administered

    during perioperative until the first 24h hours post operative

  • total amount of morphine consumption

    during first 48 hours post operative

  • visual analog scale

    during first 48 hours post operative, at 3 months and 6 months

  • +5 more secondary outcomes

Study Arms (2)

continous paravertebral block

ACTIVE COMPARATOR

echoguided thoracic continous paravertebral block was placed before the surgery. A bolus of 5 ml of ropivacaine 0.2% and 10µg of Sufentanil was injected in the catheter at the end of the abdominal time. A continuous infusion of ropivacaine 0.2% at 4ml/h was then initiated at the thoracic time. Postoperative patient-controlled analgesia consisted on an infusion of ropivacaine 0.2% at 6ml/h and a permitted bolus of 4ml every 15min as required.

Other: paravertebral blockDrug: ropivacaineDrug: Sufentanil

continous Thoracic epidural block

ACTIVE COMPARATOR

thoracic epidural catheter was inserted before the surgery. A bolus of 5 ml of ropivacaine 0.2% and 10µg of Sufentanil was injected in the catheter at the end of the abdominal time. A continuous infusion of ropivacaine 0.2% at 4ml/h was then initiated at the thoracic time. Postoperative patient-controlled analgesia consisted on an infusion of ropivacaine 0.2% at 6ml/h and a permitted bolus of 4ml every 15min as required.

Other: thoracic epidural blockDrug: ropivacaineDrug: Sufentanil

Interventions

in the paravertebral block , the catheter was placed under ultrasound echography , at the right thoracic T4/T5 level

continous paravertebral block

in the epidural block the catheter was inserted without echography , at T4/T5 level

continous Thoracic epidural block
continous Thoracic epidural blockcontinous paravertebral block
continous Thoracic epidural blockcontinous paravertebral block

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA score 1 to 3
  • oesophagectomy : abdominal time with laparoscopy ans thoracic time with thoracotomy

You may not qualify if:

  • pregnancy
  • Uncooperative patient
  • patient refusal
  • Coagulopathy
  • allergy to local anesthetic
  • Psychological Disorders
  • Failure to install the epidural or paravertebral catheter. The patient will therefore be excluded secondarily but will be able to benefit from an alternative technique for the management of his pain.
  • Sepsis
  • Skin infection at the puncture site
  • Allergy to local anesthetics
  • Esophagectomy with cervical surgical time
  • Patient with chronic pain EVA\> 4 before surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU , Hôpital Claude Huriez

Lille, France

Location

Related Publications (1)

  • Davies RG, Myles PS, Graham JM. A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy--a systematic review and meta-analysis of randomized trials. Br J Anaesth. 2006 Apr;96(4):418-26. doi: 10.1093/bja/ael020. Epub 2006 Feb 13.

    PMID: 16476698BACKGROUND

MeSH Terms

Conditions

Esophageal Neoplasms

Interventions

RopivacaineSufentanil

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal Diseases

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesFentanylPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Gilles Lebuffe, MD, PhD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2017

First Posted

June 14, 2017

Study Start

December 1, 2013

Primary Completion

July 1, 2016

Study Completion

January 1, 2017

Last Updated

June 14, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will not share

Locations